Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sun Pharma (Tamlet)

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of medical drugs. The company is engaged in the development and production of the Tamsulosin+Tolterodine products used for the treatment of men with lower urinary tract symptoms and overactive bladder.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • SUN HOUSE, CTS No. 201 B/1
  • Western Express Highway, Goregaon (East)
  • Mumbai, Maharashtra 400063
  • India

Sun Pharma (Tamlet) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Sun Pharma (Tamlet)‘s full profile, request access.

Request full access to PitchBook

Sun Pharma (Tamlet) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Sun Pharma (Tamlet)‘s full profile, request access.

Request full access to PitchBook